Topic

Articles

How pharma leaders can convert data collected for compliance purposes from a cost center into a critical success factor.

Tapping Compliance Data to Drive Success

Amid the limitations of traditional compliance programs that emphasize control measures, here are steps biopharma companies can implement in their own cultures to ensure they’re behaving and performing with integrity.

Culture and Compliance: Building a Culture of Business Ethics

Case study illustrates how compliance teams, in today’s climate,  can foster innovation across an organization to help achieve corporate goals.

Enterprise Leadership: Is Compliance Ripe for Disruption?

Xavier Duburcq is ProductLife Group’s CEO. A pharmacist, with a PhD in Immunology, Xavier was involved in his early career in the development of new medical devices for the detection of hepatitis, HIV, malaria and other blood viruses at Sedac Therapeutics and Biorad. 

Xavier Duburcq describes how pharma leaders can convert compliance from a cost center to a critical success factor.

Leverage Compliance Activities to Drive Data-Driven Success

Rob Besse is Vice President, Archbow Consulting.

It is vital to begin asking questions about your company’s DSCSA readiness and compliance, as well as that of your strategic partners, writes Rob Besse.

What You Need to Know about the Drug Supply Chain Security Act

Is Congress harming pharmaceutical research by limiting enforcement of improvement patents?


Attacks on Pharmaceutical Improvement Patents

How pharma companies can bolster their quality management programs to meet FDA’s evolving compliance requirements.   

Compliance as Usual Doesn’t Cut it Anymore

Tom Kottler is co-founder and Chief Executive Officer of HealthPrize Technologies, the leading digital adherence and patient engagement platform for life science companies. Kottler has led multiple high-growth organizations during his career, including Advanced BioHealing, which was acquired by Shire for $750 million, and MedAptus, an innovative healthcare IT company based in Boston, Mass.

Op-Ed: The best way to capitalize on the potential revenue influx from enterprise-level drug adherence programs is to create room at the executive table for a Chief Adherence Officer. 

It’s Time for a Chief Adherence Officer

James Clark â¨is Senior Associate at DLA Piper UK LLP.

James Clark addresses one of the key questions data protection and compliance officers are asking following the implementation of the General Data Protection Regulation -"What role am I playing under the GDPR?"

Identity Crisis: Data Protection Roles for Life Sciences Companies

Graham Francis is Product Manager at Kallik.

There’s a need, now more than ever, to balance complex regulations, rising consumer demand and shifting market realities, writes Graham Francis.

Legal